Q1 FY27 results analysis · July 31, 2026

Global Health Ltd (MEDANTA) Q1 FY27 Results Analysis: Revenue Surges 26.5%, EBITDA Margin Misses Guidance

−1.1%PAT year on year, Rs. 157.25 Cr
Cofacto ResearchPublished July 31, 20262 min readNeutral read
Quick summary

Global Health Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,304.05 Cr (+26.50% YoY) and PAT growth of -1.10% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 30, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 1,304.05 Cr (+26.50% YoY)
PAT (Q1)Rs. 157.25 Cr (-1.10% YoY)
EBITDA margin22.48% (-220 bps YoY)
EPS (Q1)Rs. 5.91 (-0.20% YoY)
Market capRs. 38,083.00 Cr
CMPRs. 1,416.40

Quarter Snapshot

Medanta delivered strong revenue growth of 26.5% YoY, the highest in recent history, driven by capacity additions and volume growth. However, EBITDA margin missed the company's own 24-26% guidance, coming in at 22.48%, as costs from expansion (finance costs, D&A, retainers) outpaced revenue. The quarter saw flat PAT, but subsidiary hospitals are maturing with a 3x jump in contribution, and new catalysts (Guwahati expansion, Indore oncology unit, medical college) position the company for medium-term improvement.

Key Investment Insights

Key Positives

  • Revenue grew 26.5% YoY to Rs.1,304.05 Cr, the strongest quarterly print in recent history.
  • Subsidiary PAT contribution (new hospitals) jumped 3x to Rs.21.42 Cr, confirming maturing of new capacity.
  • EBITDA margin expanded 58 bps QoQ to 22.48%, consistent with narrowing losses at Noida.
  • Cost of materials as % of revenue declined 95 bps YoY.

Risk Factors

  • EBITDA margin of 22.48% missed the company's own FY27 guidance of 24-26% by ~152 bps.
  • Reported PAT was flat YoY (-0.2%) and normalized PAT declined 9.6% YoY, despite 26.5% revenue growth.
  • Finance costs doubled YoY (+93.5%) and D&A rose 52.9% YoY, reflecting the capital-intensive expansion.
  • Retainers & consultants fee as % of revenue rose 213 bps YoY to 15.39% due to clinical talent onboarding.

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.